Here is a comprehensive reference on the clinical and scientific aspects of lipoproteins in diabetes. It features recent major diabetes and lipid related clinical trials, and includes tables and figures to highlight major points.

Authored by internationally well-respected scientists in the field

Arranged into two sections to readily access the required information

Describes and discusses recent major diabetes and lipid related clinical trials

Includes tables and figures to highlight major points

Authored by internationally well-respected scientists in the field Arranged into two sections to readily access the required information Describes and discusses recent major diabetes and lipid related clinical trials Includes tables and figures to highlight major points Includes supplementary material: sn.pub/extras

Autorentext

Alicia Jenkins, MBBS, MD, FRACP, FRCP
University of Oklahoma Health Sciences Center, Section of Endocrinology and Diabetes, Oklahoma City, OK, USA

Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA, FCCP, FAHA, FACC
CGH Medical Center, Sterling, IL
University of Illinois College of Medicine, Clinical Family and Community Medicine, Peoria, IL
Michigan State University College of Osteopathic Medicine, Clinical Medicine, East Lansing, MI, USA

Timothy J. Lyons, MD, FRCP
University of Oklahoma Health Sciences Center, Section of Endocrinology and Diabetes, Harold Hamm Diabetes Center, Oklahoma City, OK, USA

Zusammenfassung
Authoritative and comprehensive, Lipoproteins in Diabetes Mellitus details the many changes wrought by insulin resistance and diabetes mellitus on lipid and lipoprotein metabolism.

Inhalt

Laboratory Assessment of Lipoproteins in Diabetes.- Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin Resistance Diabetes.- Insulin Resistance and Atherosclerosis.- Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes.- Lipoprotein Metabolism and Alterations induced by insulin resistance and diabetes.- Production and Metabolism of Triglyceride-Rich Lipoproteins in both the Normal and Diabetic States.- Lipoprotein(a): Structure, Metabolism and Pathophysiology.- Lipoprotein Glycation in Diabetes Mellitus.-Lipoprotein (LDL and HDL) Oxidation in Diabetes Mellitus.- The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes.- Lipid Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes.- Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus.- Endothelial Dysfunction and Dyslipidaemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy.- Lipoproteins and Diabetic Nephropathy.- Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy.- Effects of Lifestyle (Diet, Plant Sterols, Excercise) and Glycemic Control on Lipoporteins in Diabetes.- About Randomised Clinical Trials Related to Lipoproteins in Diabetes Mellitus.- Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients.- The PPAR System in Diabetes.- Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients.- Niacin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients.- Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus.- Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes.